Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Poorer Physical and Mental Health Status Are Associated with Subsequent Opioid Prescriptions: a U.S. National Study

Abstract

Background

How physical and mental health status relate to receipt of opioid prescription remains unclear, creating uncertainty in minimizing opioid harms while avoiding pain under-treatment.

Objective

To examine the associations of physical and mental health status with subsequent opioid prescriptions.

Design

Observational study of 2005–2015 United States (U.S.) Medical Expenditure Panel Survey data.

Participants

Adult respondents (N = 78,563) participating for 2 years. The analyses focused on respondents reporting no opioid prescriptions in year 1 (N = 65,249).

Main Measures

In the primary analysis, a negative binomial regression yielding adjusted incidence rate ratios (IRRs), the dependent variable was the number of opioid prescriptions in year 2. In two secondary analyses, both logistic regressions yielding adjusted odds ratios (ORs), the dependent variables were receipt of any opioid prescription (versus none) and receipt of ≥ 6 opioid prescriptions (versus 0–5) in year 2. The key independent variables in all analyses were the SF-12 Physical and Mental Component Summary scores (PCS-12 and MCS-12, respectively; higher scores = better health status). All models adjusted for socio-demographics, health-related variables, and year.

Key Results

Primary analysis. With each 10-point decrement in year 1 PCS-12 or MCS-12 score, there were more opioid prescriptions received in year 2 (adjusted IRRs [95% CIs] 1.45 [1.39–1.52] and 1.22 [1.16–1.27], respectively). Secondary analyses. With each 10-point decrement in year 1 PCS-12 or MCS-12 score, there were higher odds in year 2 both of receiving any opioid prescription (adjusted ORs 1.23 [1.19–1.28] and 1.11 [1.08–1.15], respectively) and of receiving ≥ 6 opioid prescriptions (adjusted ORs 1.96 [1.75–2.17] and 1.37 [1.23–1.54], respectively).

Conclusions

In a nationally representative U.S. sample, both poorer physical and mental health status independently predicted receiving more opioid prescriptions received in a subsequent year, as well as receiving ≥ 6 prescriptions during the year. Our findings may contribute to a more nuanced picture of the drivers of opioid prescription.

This is a preview of subscription content, log in to check access.

Figure 1

References

  1. 1.

    Sites BD, Beach ML, Davis MA. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med. 2014;39:6-12.

  2. 2.

    Alexander LM, Keahey D, Dixon K. Opioid use disorder: a public health emergency. JAAPA. 2018;31:47-52.

  3. 3.

    HHS acting secretary declares public health emergency to address national opioid crisis. October 26, 2017. Available at: https://www.hhs.gov/about/news/2017/10/26/hhs-acting-secretary-declares-public-health-emergency-address-national-opioid-crisis.html. Accessed August 21, 2019.

  4. 4.

    The opioid crisis in the USA: a public health emergency. Lancet. 2017;390:2016.

  5. 5.

    Dowell D, Haegerich TM, Chou R. CDC Guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315:1624-45.

  6. 6.

    Manchikanti L, Kaye AM, Knezevic NN, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017;20:S3-S92.

  7. 7.

    Karafin MS, Singavi A, Hussain J, et al. Predictive factors of daily opioid use and quality of life in adults with sickle cell disease. Hematology. 2018;23:856-63.

  8. 8.

    Anderson A, Click B, Ramos-Rivers C, et al. The association between sustained poor quality of life and future opioid use in inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:1380-8.

  9. 9.

    Dillie KS, Fleming MF, Mundt MP, et al. Quality of life associated with daily opioid therapy in a primary care chronic pain sample. J Am Board Fam Med. 2008;21:108-17.

  10. 10.

    Davis MA, Lin LA, Liu H, Sites BD. Prescription opioid use among adults with mental health disorders in the United States. J Am Board Fam Med. 2017;30:407-17.

  11. 11.

    Torrance N, Lawson KD, Afolabi E, et al. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter? Pain. 2014;155:1996-2004.

  12. 12.

    Bao Y, Sturm R, Croghan TW. A national study of the effect of chronic pain on the use of health care by depressed persons. Psychiatr Serv. 2003;54:693-7.

  13. 13.

    Linton SJ, Shaw WS. Impact of psychological factors in the experience of pain. Phys Ther. 2011;91:700-11.

  14. 14.

    Turk DC, Okifuji A. What factors affect physicians’ decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain. 1997;13:330-6.

  15. 15.

    Patients with mental disorders get half of all opioid prescriptions. Kaiser Health News. June 26, 2017.

  16. 16.

    Goesling J, Henry MJ, Moser SE, et al. Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. J Pain. 2015;16:844-51.

  17. 17.

    Halbert BT, Davis RB, Wee CC. Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain. 2016;157:2452-7.

  18. 18.

    Sullivan MD, Edlund MJ, Zhang L, et al. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166:2087-93.

  19. 19.

    Weinberger AH, Gbedemah M, Martinez AM, et al. Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups. Psychol Med. 2018;48:1308-15.

  20. 20.

    Mojtabai R, Jorm AF. Trends in psychological distress, depressive episodes and mental health treatment-seeking in the United States: 2001-2012. J Affect Disord. 2015;174:556-61.

  21. 21.

    Wittayanukorn S, Qian J, Hansen RA. Prevalence of depressive symptoms and predictors of treatment among U.S. adults from 2005 to 2010. Gen Hosp Psychiatry. 2014;36:330-6.

  22. 22.

    Carvalho AS, Martins Pereira S, Jacomo A, et al. Ethical decision making in pain management: a conceptual framework. J Pain Res. 2018;11:967-76.

  23. 23.

    Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32:4149-54.

  24. 24.

    Jukic M, Puljak L. Legal and ethical aspects of pain management. Acta Med Acad. 2018;47:18-26.

  25. 25.

    Seers T, Derry S, Seers K, et al. Professionals underestimate patients’ pain: a comprehensive review. Pain. 2018;159:811-8.

  26. 26.

    Kroenke K, Cheville A. Management of chronic pain in the aftermath of the opioid backlash. JAMA. 2017;317:2365-6.

  27. 27.

    Fishman S, Berger L. The War on Pain. New York, NY: Harper Perennial; 2001.

  28. 28.

    Dineen KK, DuBois JM. Between a rock and a hard place: can physicians prescribe opioid to treat pain adequately while avoiding legal sanction? Am J Law Med. 2016;42:7-52.

  29. 29.

    Serafini M. The physicians’ quandary with opioids: pain versus addiction. NEJM Catalyst. Available at: https://catalyst.nejm.org/quandary-opioids-chronic-pain-addiction/. Accessed August 21, 2019.

  30. 30.

    Survey Background - Medical Expenditure Panel Survey. Available at: https://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp. Accessed August 21, 2019.

  31. 31.

    Response rates - Medical Expenditure Panel Survey (MEPS). Available at: https://meps.ahrq.gov/survey_comp/hc_response_rate.jsp. Accessed August 21, 2019.

  32. 32.

    Ware J Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-33.

  33. 33.

    Nosyk B, Sun H, Guh DP, et al. The quality of eight health status measures were compared for chronic opioid dependence. J Clin Epidemiol. 2010;63:1132-44.

  34. 34.

    Payne EH, Hardin JW, Egede LE, et al. Approaches for dealing with various sources of overdispersion in modeling count data: scale adjustment versus modeling. Stat Methods Med Res. 2017;26:1802-23.

  35. 35.

    Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999;15:141-55.

  36. 36.

    Diaz-Arribas MJ, Fernandez-Serrano M, Royuela A, et al. Minimal clinically important difference in quality of life for patients with low back pain. Spine. 2017;42:1908-16.

  37. 37.

    Jayadevappa R, Cook R, Chhatre S. Minimal important difference to infer changes in health-related quality of life - a systematic review. J Clin Epidemiol. 2017;89:188-98.

  38. 38.

    Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC. Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care. 2000;38:1141-50.

  39. 39.

    Vilagut G, Forero CG, Pinto-Meza A, et al. The mental component of the short-form 12 health survey (SF-12) as a measure of depressive disorders in the general population: results with three alternative scoring methods. Value Health. 2013;16:564-73

  40. 40.

    Mojtabai R. National trends in long-term use of prescription opioids. Pharmacoepidemiol Drug Saf. 2018;27:526-34.

  41. 41.

    Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790.

Download references

Author information

Correspondence to Anthony Jerant MD.

Ethics declarations

Ethical approval for the study was provided by the University of California Davis Institutional Review Board (exempted status).

Conflict of interest

The authors have no conflicts of interest to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jerant, A., Agnoli, A. & Franks, P. Poorer Physical and Mental Health Status Are Associated with Subsequent Opioid Prescriptions: a U.S. National Study. J GEN INTERN MED 35, 554–560 (2020). https://doi.org/10.1007/s11606-019-05401-z

Download citation

KEY WORDS

  • analgesics
  • opioid
  • health status
  • pain
  • surveys and questionnaires
  • United States